Yan, Kaixuan
Zheng, Jiaxing
Kluth, Mark Andreas
Li, Lin
Ganss, Christoph
Yard, Benito
Magdeburg, Richard
Frank, Markus H.
Pallavi, Prama http://orcid.org/0000-0001-7788-6645
Keese, Michael
Funding for this research was provided by:
TICEBA GmbH
Medizinische Fakultät Mannheim der Universität Heidelberg
Article History
Received: 14 March 2022
Accepted: 21 December 2022
First Online: 9 February 2023
Declarations
:
: The protocol of HUVECs isolation was approved by the local ethics committee (Ethikkommission II der Medizinische Fakultät Mannheim AZ 2015-518N-MA). All experimental procedures were performed according to the EC guideline EC 2010/63/EU and have been approved by the local German legislation (35-9185.81/G[1]239/18). 8-week-old male ApoE<sup>−/−</sup> mice with the C57BL/6J background were purchased from Charles River Laboratories.
: Not applicable.
: MAK is CSO of TICEBA GmbH, the manufacturer of the ABCB5<sup>+</sup> MSCs. Remaining authors declare no competing interests.